Medication info
NARIGENTA Tablet 5mg (Linagliptin)

NARIGENTA Tablet 5mg (Linagliptin)

Prescription medicationTablet
Ingredient · strength
Linagliptin›5mg / 1 tablet
Manufacturer / importer
Farmagen Science Co., Ltd.
Appearance
Bright red round film-coated tablet
Packaging
30 tablets/box [(10 tablets/Alu-Alu X 3)]
Approval status
Active

MFDS item code 202004750 · Approved 2020.06.29 · Insurance code 670104930

Summary

Main use
Improvement of blood glucose control in type 2 diabetes mellitus
Who uses it
Adults
Adult dosage
The recommended dose of this product is 5mg once daily. It may be administered with or without food. When administered concomitantly with insulin or an insulin secretagogue (e.g., sulfonylurea), a lower dose of insulin and the insulin secretagogue may be needed to minimize the risk of hypoglycemia.

Ingredients

Manufacturer
Farmagen Science Co., Ltd.

Efficacy & effects

Improvement of blood glucose control in type 2 diabetes mellitus

View approved original text

This drug is used to assist with blood sugar control in patients with type 2 diabetes. It can be administered alone or in combination with other medications alongside dietary and exercise therapies. This helps effectively manage blood sugar levels and aids in the prevention of complications arising from diabetes. It can be used as an appropriate treatment method based on the patient's condition.

Dosage and Administration

Adult dosage

The recommended dose of this product is 5mg once daily. It may be administered with or without food. When administered concomitantly with insulin or an insulin secretagogue (e.g., sulfonylurea), a lower dose of insulin and the insulin secretagogue may be needed to minimize the risk of hypoglycemia.

Precautions

This medication should not be used in patients who are allergic to the active ingredient or other components. It is not to be administered to patients with type 1 diabetes or diabetic ketoacidosis. Caution is required when used with insulin or sulfonylureas which may induce hypoglycemia, as dose adjustments may be necessary to reduce the risk of low blood sugar. It should be administered with caution in patients with heart failure, and if symptoms of acute pancreatitis occur, discontinuation and consultation with a physician is necessary. If symptoms of skin abnormalities such as bullous pemphigoid appear, discontinue use and consult a specialist. While taking this medication, patients should be vigilant for signs of hypoglycemia, and if severe joint pain occurs, discontinuation may be required. The use of this drug is not recommended for pregnant women, and caution is advised for breastfeeding women. Safety and efficacy have not been sufficiently established for use in children and adolescents. It may be used in elderly patients or those with reduced renal or liver function without dose adjustments. In cases of overdose, it is necessary to remove any unabsorbed drug from the gastrointestinal tract and observe symptoms for appropriate treatment. This drug should be stored out of the reach of children and should not be transferred to another container.

Side effects

Hypoglycemia, pancreatitis, bullous pemphigoid, nasopharyngitis, hypersensitivity, angioedema, urticaria, cough, constipation, oral ulcer formation, rash, arthritis accompanied by severe and disabling pain, rhabdomyolysis, weight gain, increased lipase, increased amylase, dyspepsia, edema, facial edema, peripheral edema, weight loss, increased appetite, constipation, abdominal pain, enterocolitis, bowel obstruction, gastritis, herpes zoster, cystitis, acute pyelonephritis, bronchitis, vestibular neuronitis, sepsis, pneumonia, decreased appetite, dehydration, hyperglycemia, cerebral infarction, speech disorders, Alzheimer's dementia, chest pain, fever, facial swelling, fatigue, death, chronic obstructive pulmonary disease, asthma, diabetic foot, skin lesions, liver metastasis, acute leukemia, basal cell carcinoma, non-small cell lung cancer, malignant pericardial effusion, gastric cancer, rectal cancer, pancreatic cancer, meniscus injury, pneumoconiosis, congestive heart failure, angina, acute myocardial infarction, unstable angina, cardiac arrest, diabetic retinopathy, acute kidney injury, end-stage renal disease, acute cholangitis, acute cholecystitis, cholangitis, dizziness, kidney transplant failure, anemia, nausea, diarrhea, vomiting, gastroesophageal reflux disease, gastritis, dizziness, sensory impairment, chest discomfort, asthenia, epistaxis, oropharyngeal pain, voice disorders, allergic rhinitis, exercise-induced dyspnea, moist cough, rhinorrhea, lung mass, arthralgia, osteoporosis, arthropathy, musculoskeletal discomfort, myositis, myalgia, soft tissue mass, postmenopausal osteoporosis, rotator cuff syndrome, increased triglycerides in blood, increased urinary albumin/creatinine ratio, positive urine leukocyte, decreased hemoglobin, increased potassium in blood, increased creatinine in blood, increased creatine phosphokinase activity in blood, increased ALT, increased AST, androgenetic alopecia, hyperhidrosis, hair loss, dermatitis, anxiety, mood disorders, insomnia, depression, contusion, bone contusion, concussion, bone fracture, hand fracture, laceration, palpitations, dry eye, glaucoma, cataract, ocular discomfort, allergic conjunctivitis, polyuria, proteinuria, abdominal pressure incontinence, hematuria, hypotension, flushing, fatty liver, gallstones, hearing loss, erectile dysfunction, goiter, pruritus, hypertension, benign prostatic hyperplasia

Not everyone experiences these, and they can vary from person to person.

Storage

This drug should be stored in a tightly closed container to protect it from air and moisture. It is best to maintain a storage temperature between 1 and 30 degrees Celsius.

Appearance and packaging

Appearance

Bright red round film-coated tablet

Package unit

30 tablets/box [(10 tablets/Alu-Alu X 3)]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.